May 8, 2014 / 5:41 AM / in 4 years

Stada shrugs off Ukraine crisis to post flat net profit

FRANKFURT, May 8 (Reuters) - Stada Arzneimittel, a German generic drugmaker which makes about 20 percent of its sales in Russia, shrugged off a worsening crisis between Russia and Ukraine to report rising sales and flat net profit in the first quarter.

Quarterly net profit came in at 35.0 million euros ($48.7 million), barely changed from the previous year and in line with the average estimate of 34.5 million in a Reuters poll.

The company in March scrapped its sales and profit targets for this year, blaming political tensions that have pushed the rouble to an all-time low.

Stada on Thursday said it was still forecasting slight growth in annual sales, adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) and adjusted net profit. ($1 = 0.7183 Euros) (Reporting by Caroline Copley; Editing by Ludwig Burger)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below